Filter

91 - 100 of 363 Results

  • ACIP Vote Drives Online Engagement About Hepatitis B Vaccine, And Posts Claim a VAERS “Cover-Up” of COVID-19 Vaccine Deaths — The Monitor

    Feature

    Nearly two weeks after a CDC advisory panel voted to end the recommendation for newborn hepatitis B vaccination, conversations about vaccination schedules and parental choice remain elevated. Meanwhile, narratives about an FDA memo alleging COVID-19 vaccines caused 10 pediatric deaths have shifted toward claims of a government cover-up.

  • New KFF-Washington Post Poll Explores Parents’ Vaccine Attitudes, and Confusion Follows ACIP Meeting on Vaccine Recommendations – The Monitor

    Feature

    This volume explores findings from the KFF-Washington Post Survey of Parents on views of childhood vaccines; how ACIP may have contributed to concerns about hepatitis B and COVID-19 vaccines; recent HHS warnings about alleged links between Tylenol use in pregnancy and autism; and AI-generated deepfakes impersonating doctors to sell products.

  • KFF COVID-19 Vaccine Monitor: Pregnancy Misinformation – May 2022

    Poll Finding

    Misinformation and confusion about the COVID-19 vaccines and pregnancy is common among women who are pregnant or planning to become pregnant, with about three in ten saying they believe at least one false statement regarding the COVID-19 vaccines.

  • New Nationwide Poll by the Kaiser Family Foundation and The Undefeated Reveals Distrust of the Health Care System Among Black Americans

    News Release

    Half of African Americans say they will not take a coronavirus vaccine KFF/The Undefeated poll shows disparate views on health care between Black and white America Poll results published on The Undefeated beginning today The Kaiser Family Foundation (KFF) and The Undefeated have conducted a joint nationwide survey that explores the views and experiences of African Americans during the coronavirus pandemic. Despite the disproportionate impact of the virus on Black communities, 49 percent of African…

  • How Much Could COVID-19 Vaccines Cost the U.S. After Commercialization?

    Issue Brief

    This analysis illustrates the potential total cost of Pfizer and Moderna COVID-19 vaccines, based on their publicly-announced expected prices, once they enter the U.S. commercial market. It compares the average price paid by the federal government for the COVID-19 bivalent boosters to the estimated average commercial prices across different scenarios.

  • KFF COVID-19 Vaccine Monitor: November 2021

    Poll Finding

    This report shows an increasing share of the public are frustrated about the status of COVID-19 vaccinations in the U.S.. The share of fully vaccinated adults who report receiving a booster dose has more than doubled in the last month, though vaccine uptake overall is little changed. The poll also explores attitudes towards federal mandates on workplace vaccinations and the pandemic's toll on different groups.

  • Dec. 3 Web Briefing: What Happens Once There is a COVID-19 Vaccine? Key Challenges to Vaccinating America

    Event Date:
    Event

    Encouraging reports about several COVID-19 vaccine candidates is raising hopes that there will soon be one or more vaccines proven safe and effective, starting a race to produce, distribute, and administer it to essential workers, people at high risk, and the public, including those who may start out with skepticism about the risks posed by COVID-19 and the safety and necessity of vaccination. KFF held an interactive web briefing on Thursday, December 3 to walk…

  • Estimates of the Initial Priority Population for COVID-19 Vaccination by State

    Issue Brief

    This analysis provides new national and state-level estimates of the number of health care workers and long-term care residents who are expected to be part of the group first in line to receive the COVID-19 vaccine to gain insight into how this initial priority population varies across states.

  • New National and State Estimates for Recommended COVID-19 Vaccination Priority Population

    News Release

    This month the Centers for Disease Control and Prevention (CDC) adopted a recommendation that health care workers and long-term care residents should be the first to receive the COVID-19 vaccine once it is authorized or approved by the FDA. A new KFF analysis estimates there are 15.5 million people working in health care settings who have direct patient contact, 1.2 million nursing facility residents and another 800,000 assisted living facility residents nationwide. These 17.6 million…